Prospects of therapies targeting resistant bacteria-New challenges 20 years post emergence of vancomycin-resistant enterococcus.
Brickner
Steven J
SJ
Pfizer Global Research & Development, Antibacterials Medicinal Chemistry, Groton, CT 06340, USA.
Mobashery
Shahriar
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control; D024881:Drug Resistance, Bacterial; D016983:Enterococcus / Q000187:drug effects; D006801:Humans; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents